NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis

NCT02076685 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hepatotoxicity

Interventions

DRUG: isoniazid

Sponsor

National Taiwan University Hospital